Prelude Capital Management’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-194,465
Closed -$299K 1350
2024
Q1
$299K Buy
+194,465
New +$318K 0.02% 892
2023
Q4
Sell
-55,192
Closed -$164K 1222
2023
Q3
$164K Buy
55,192
+9,951
+22% +$37.9K 0.01% 944
2023
Q2
$202K Buy
+45,241
New +$203K 0.01% 846
2019
Q2
Sell
-126
Closed -$5K 1875
2019
Q1
$5K Sell
126
-15
-11% -$559 ﹤0.01% 1641
2018
Q4
$5K Buy
+141
New +$4.34K ﹤0.01% 1612
2018
Q3
Sell
-102
Closed -$3K 1864
2018
Q2
$3K Sell
102
-53
-34% -$1.83K ﹤0.01% 1586
2018
Q1
$4K Buy
+155
New +$4.09K ﹤0.01% 1426

Other funds holding IFRX

Prelude Capital Management's IFRX Position: Q2 2024 in Review

Prelude Capital Management sold out of InflaRx (IFRX) in Q2 2024, closing a stake of 194,465 shares — an estimated $299K sold.

Prelude Capital Management first reported a position in IFRX in Q1 2018 and held it in 7 quarters. The position peaked at $299K in Q1 2024. 33 funds tracked by Wall St. Rank hold IFRX as of Q2 2024.

  • Prelude Capital Management reported no remaining InflaRx position as of Q2 2024 after selling out during the quarter.
  • Prelude Capital Management sold 194,465 InflaRx shares in Q2 2024, an estimated $299K.
  • Prelude Capital Management first reported a position in InflaRx in Q1 2018 and held it in 7 quarters.
  • Prelude Capital Management's InflaRx position peaked at $299K in Q1 2024.
  • 33 funds tracked by Wall St. Rank held InflaRx as of Q2 2024.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.